Fresenius in talks to acquire US-based Akorn

13 April 2017 - Deborah Wilkes


German healthcare company Fresenius is in talks to acquire US generics, OTC and animal health company Akorn.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: